Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Paul Thompson MD
Paul D. Thompson MD Advisory Board
Peter Libby MD
Peter Libby MD Advisory Board
Anne Valente MD
Anne Marie Valente MD Advisory Board
See All Experts
story of the week
Published in Cardiology

Journal Scan / Research · May 11, 2017

The Nocebo Effect Claims Statins Users

The Lancet

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Paul Thompson MD

The Lancet
Adverse Events Associated With Unblinded, but Not With Blinded, Statin Therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): A Randomised Double-Blind Placebo-Controlled Trial and Its Non-Randomised Non-Blind Extension Phase
Lancet 2017 May 02;[EPub Ahead of Print], A Gupta, D Thompson, A Whitehouse, T Collier, B Dahlof, N Poulter, R Collins, P Sever

Further Reading

Most Read This Week

Recently Updated